Trial Profile
A Comparison of Active and Usual Titration Regimen in the Treatment of Hypertensive Patients Insufficiently Controlled by Monotherapy. A Randomised, Open-Label, Multicentre, Phase IIIb/IV Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2012
Price :
$35
*
At a glance
- Drugs Irbesartan/hydrochlorothiazide (Primary)
- Indications Essential hypertension; Hypertension
- Focus Therapeutic Use
- Acronyms ACTUAL
- Sponsors Sanofi
- 21 Jun 2010 Results have been presented at the 20th European Meeting on Hypertension.
- 11 Sep 2009 Actual end date (July 2009) added as reported by ClinicalTrials.gov.
- 11 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.